{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:14:11Z","timestamp":1783498451462,"version":"3.55.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00415-026-13914-x","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:03:35Z","timestamp":1780661015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging insight in genetics and therapies in young-onset Parkinson\u2019s disease (YOPD): a comprehensive review"],"prefix":"10.1007","volume":"273","author":[{"given":"Grace","family":"Hey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6660-2213","authenticated-orcid":false,"given":"Gilberto","family":"Perez Rodriguez Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hedera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Ramirez-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"3","key":"13914_CR1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3233\/jpd-202464","volume":"11","author":"E Camerucci","year":"2021","unstructured":"Camerucci E, Stang CD, Hajeb M et al (2021) Early-onset parkinsonism and early-onset Parkinson\u2019s disease: a population-based study (2010-2015). J Parkinson\u2019s Dis 11(3):1197\u20131207. https:\/\/doi.org\/10.3233\/jpd-202464","journal-title":"J Parkinson's Dis"},{"issue":"7","key":"13914_CR2","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/mdc3.13523","volume":"9","author":"R Mehanna","year":"2022","unstructured":"Mehanna R, Smilowska K, Fleisher J et al (2022) Age cutoff for early\u2010onset Parkinson\u2019s disease: recommendations from the International Parkinson and Movement Disorder Society Task Force on early onset Parkinson\u2019s disease. Mov Disord Clin Pract 9(7):869\u2013878. https:\/\/doi.org\/10.1002\/mdc3.13523","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"13914_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.22966","volume":"25","author":"Y Winter","year":"2010","unstructured":"Winter Y, Bezdolnyy Y, Katunina E et al (2010) Incidence of Parkinson\u2019s disease and atypical parkinsonism: Russian population-based study. Mov Disord 25(3):349\u2013356. https:\/\/doi.org\/10.1002\/mds.22966","journal-title":"Mov Disord"},{"issue":"8","key":"13914_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/jnnp.2008.168211","volume":"80","author":"G Alves","year":"2009","unstructured":"Alves G, Muller B, Herlofson K et al (2009) Incidence of Parkinson\u2019s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851\u2013857. https:\/\/doi.org\/10.1136\/jnnp.2008.168211","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"13914_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200605","volume":"16","author":"GE Hey","year":"2026","unstructured":"Hey GE, Kamo H, Perez Rodriguez Garcia G et al (2026) Long-term outcomes of Subthalamic Nucleus and Globus Pallidus Interna Deep brain stimulation for Young-onset Parkinson Disease. Neurol Clin Pract 16(3):e200605. https:\/\/doi.org\/10.1212\/CPJ.0000000000200605","journal-title":"Neurol Clin Pract"},{"issue":"8","key":"13914_CR6","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.parkreldis.2015.06.003","volume":"21","author":"P Ylikotila","year":"2015","unstructured":"Ylikotila P, Tiirikka T, Moilanen JS, K\u00e4\u00e4ri\u00e4inen H, Marttila R, Majamaa K (2015) Epidemiology of early-onset Parkinson\u2019s disease in Finland. Parkinsonism Relat Disord 21(8):938\u2013942. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.003","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.parkreldis.2022.09.003","volume":"104","author":"E Camerucci","year":"2022","unstructured":"Camerucci E, Mullan AF, Turcano P, Stang CD, Bower J, Savica R (2022) 40-year incidence of early-onset Parkinson\u2019s disease (EOPD) in Southeast Minnesota. Parkinsonism Relat Disord 104:64\u201367. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.09.003","journal-title":"Parkinsonism Relat Disord"},{"issue":"s1","key":"13914_CR8","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3233\/jpd-202135","volume":"10","author":"B Post","year":"2020","unstructured":"Post B, van den Heuvel L, van Prooije T et al (2020) Young onset Parkinson\u2019s disease: a modern and tailored approach. J Parkinson\u2019s Dis 10(s1):S29\u2013S36. https:\/\/doi.org\/10.3233\/jpd-202135","journal-title":"J Parkinson's Dis"},{"issue":"2","key":"13914_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.parkreldis.2012.09.014","volume":"19","author":"AW Willis","year":"2013","unstructured":"Willis AW, Schootman M, Kung N, Racette BA (2013) Epidemiology and neuropsychiatric manifestations of young onset Parkinson\u2019s disease in the United States. Parkinsonism Relat Disord 19(2):202\u2013206. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.09.014","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"13914_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.14802\/jmd.21029","volume":"14","author":"E Hustad","year":"2021","unstructured":"Hustad E, Myklebust T\u00c5, Gulati S, Aasly JO (2021) Increased mortality in young-onset Parkinson\u2019s disease. J Mov Disord 14(3):214\u2013220. https:\/\/doi.org\/10.14802\/jmd.21029","journal-title":"J Mov Disord"},{"issue":"12","key":"13914_CR11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/jnnp.2006.100107","volume":"78","author":"LS Ishihara","year":"2007","unstructured":"Ishihara LS, Cheesbrough A, Brayne C, Schrag A (2007) Estimated life expectancy of Parkinson\u2019s patients compared with the UK population. J Neurol Neurosurg Psychiatry 78(12):1304\u20131309. https:\/\/doi.org\/10.1136\/jnnp.2006.100107","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"13914_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.parkreldis.2014.02.013","volume":"20","author":"R Mehanna","year":"2014","unstructured":"Mehanna R, Moore S, Hou JG, Sarwar AI, Lai EC (2014) Comparing clinical features of young onset, middle onset and late onset Parkinson\u2019s disease. Parkinsonism Relat Disord 20(5):530\u2013534. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"13914_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70659","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Wang H, He X et al (2025) The evolving global burden of young-onset Parkinson\u2019s disease (1990-2021): regional, gender, and age disparities in the context of rising incidence and declining mortality. Brain Behav 15(7):e70659. https:\/\/doi.org\/10.1002\/brb3.70659","journal-title":"Brain Behav"},{"key":"13914_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107778","volume":"134","author":"J Wang","year":"2025","unstructured":"Wang J, Cheng N, Yao Z et al (2025) Early-onset Parkinson\u2019s disease, regional and national burden, and its attributable risk factors in 204 countries and regions from 1990 to 2021: results from the global burden of disease study 2021. Parkinsonism Relat Disord 134:107778. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107778","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"13914_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00702-021-02370-8","volume":"128","author":"T Schirinzi","year":"2021","unstructured":"Schirinzi T, Grillo P, Di Lazzaro G et al (2021) Effects of head trauma and sport participation in young-onset Parkinson\u2019s disease. J Neural Transm 128(8):1185\u20131193. https:\/\/doi.org\/10.1007\/s00702-021-02370-8","journal-title":"J Neural Transm"},{"key":"13914_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.parkreldis.2019.01.010","volume":"63","author":"M Ruiz-Lopez","year":"2019","unstructured":"Ruiz-Lopez M, Freitas ME, Oliveira LM et al (2019) Diagnostic delay in Parkinson\u2019s disease caused by PRKN mutations. Parkinsonism Relat Disord 63:217\u2013220. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.010","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.parkreldis.2019.06.020","volume":"65","author":"M Borsche","year":"2019","unstructured":"Borsche M, Balck A, Kasten M, Lohmann K, Klein C, Bruggemann N (2019) The sooner, the later - delayed diagnosis in Parkinson\u2019s disease due to Parkin mutations. Parkinsonism Relat Disord 65:284\u2013285. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.020","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"13914_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1002\/mds.23763","volume":"26","author":"MDW Knipe","year":"2011","unstructured":"Knipe MDW, Wickremaratchi MM, Wyatt-Haines E, Morris HR, Ben-Shlomo Y (2011) Quality of life in young- compared with late-onset Parkinson\u2019s disease. Mov Disord 26(11):2011\u20132018. https:\/\/doi.org\/10.1002\/mds.23763","journal-title":"Mov Disord"},{"key":"13914_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.parkreldis.2019.06.001","volume":"65","author":"R Mehanna","year":"2019","unstructured":"Mehanna R, Jankovic J (2019) Young-onset Parkinson\u2019s disease: its unique features and their impact on quality of life. Parkinsonism Relat Disord 65:39\u201348. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.001","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13914_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/cjn.2021.40","volume":"49","author":"PL Kukkle","year":"2021","unstructured":"Kukkle PL, Goyal V, Geetha TS et al (2021) Clinical study of 668 Indian subjects with juvenile, young, and early onset Parkinson\u2019s disease. Can J Neurol Sci 49(1):93\u2013101. https:\/\/doi.org\/10.1017\/cjn.2021.40","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"13914_CR21","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00415-020-10333-4","volume":"268","author":"R Ou","year":"2021","unstructured":"Ou R, Wei Q, Hou Y et al (2021) Suicidal ideation in early-onset Parkinson\u2019s disease. J Neurol 268(5):1876\u20131884. https:\/\/doi.org\/10.1007\/s00415-020-10333-4","journal-title":"J Neurol"},{"issue":"11","key":"13914_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/mds.10527","volume":"18","author":"A Schrag","year":"2003","unstructured":"Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M (2003) Young- versus older-onset Parkinson\u2019s disease: impact of disease and psychosocial consequences. Mov Disord 18(11):1250\u20131256. https:\/\/doi.org\/10.1002\/mds.10527","journal-title":"Mov Disord"},{"issue":"2","key":"13914_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.parkreldis.2007.07.012","volume":"14","author":"SM Calne","year":"2008","unstructured":"Calne SM, Lidstone SC, Kumar A (2008) Psychosocial issues in young-onset Parkinson\u2019s disease: current research and challenges. Parkinsonism Relat Disord 14(2):143\u2013150. https:\/\/doi.org\/10.1016\/j.parkreldis.2007.07.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"13914_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/00207454.2015.1010646","volume":"126","author":"H Tang","year":"2015","unstructured":"Tang H, Huang J, Nie K et al (2015) Cognitive profile of Parkinson\u2019s disease patients: a comparative study between early-onset and late-onset Parkinson\u2019s disease. Int J Neurosci 126(3):227\u2013234. https:\/\/doi.org\/10.3109\/00207454.2015.1010646","journal-title":"Int J Neurosci"},{"key":"13914_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.749471","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Ou R, Yang T et al (2021) Different associated factors of subjective cognitive complaints in patients with Early- and late-onset Parkinson\u2019s Disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.749471","journal-title":"Front Neurol"},{"issue":"4","key":"13914_CR26","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3233\/jpd-202066","volume":"10","author":"L Vela-Desojo","year":"2020","unstructured":"Vela-Desojo L, Urso D, Kurtis-Urra M et al (2020) Sexual dysfunction in early-onset Parkinson\u2019s disease: a cross-sectional, multicenter study. J Parkinsons Dis 10(4):1621\u20131629. https:\/\/doi.org\/10.3233\/jpd-202066","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"13914_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/09638280500165120","volume":"28","author":"P Banks","year":"2010","unstructured":"Banks P, Lawrence M (2010) The Disability Discrimination Act, a necessary, but not sufficient safeguard for people with progressive conditions in the workplace? The experiences of younger people with Parkinson\u2019s disease. Disabil Rehabil 28(1):13\u201324. https:\/\/doi.org\/10.1080\/09638280500165120","journal-title":"Disabil Rehabil"},{"key":"13914_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.108174","volume":"143","author":"B McDaniels","year":"2026","unstructured":"McDaniels B, Choi H, Kim BJ, Fricano R, Subramanian I (2026) Quality of life in early-onset Parkinson\u2019s disease: a multivariate examination of psychosocial and demographic correlates. Parkinsonism Relat Disord 143:108174. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108174","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.108074","volume":"141","author":"B McDaniels","year":"2025","unstructured":"McDaniels B, Choi H, Fricano R, Kim BJ, Subramanian I (2025) Apathy\u2019s hidden pathways: psychosocial mediators of quality of life among people with early-onset Parkinson\u2019s disease. Parkinsonism Relat Disord 141:108074. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.108074","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13914_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mdc3.13353","volume":"9","author":"HM Holden","year":"2022","unstructured":"Holden HM, Schweer CN, Tr\u00f6ster AI (2022) Impact of mild cognitive impairment on quality of life in young and typical onset Parkinson\u2019s disease. Mov Disord Clin Pract 9(1):69\u201375. https:\/\/doi.org\/10.1002\/mdc3.13353","journal-title":"Mov Disord Clin Pract"},{"issue":"8","key":"13914_CR31","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1007\/s00415-024-12474-2","volume":"271","author":"WM Kapelle","year":"2024","unstructured":"Kapelle WM, Geerlings AD, Mutsaers I, Bloem BR, Meinders MJ, Post B (2024) Unveiling the invisible: a qualitative interview study on the impact of young onset Parkinson\u2019s disease on (ex-partners). J Neurol 271(8):5312\u20135325. https:\/\/doi.org\/10.1007\/s00415-024-12474-2","journal-title":"J Neurol"},{"issue":"10","key":"13914_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.parkreldis.2011.07.008","volume":"17","author":"A Srivastava","year":"2011","unstructured":"Srivastava A, Tang MX, Mejia-Santana H et al (2011) The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat Disord 17(10):740\u2013744. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.07.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"13914_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/mds.24999","volume":"27","author":"M Kasten","year":"2012","unstructured":"Kasten M, Kertelge L, Tadic V et al (2012) Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson\u2019s disease. Mov Disord 27(6):754\u2013759. https:\/\/doi.org\/10.1002\/mds.24999","journal-title":"Mov Disord"},{"issue":"11","key":"13914_CR34","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant \u03b1-synuclein linked to early-onset Parkinson disease. Nat Med 4(11):1318\u20131320. https:\/\/doi.org\/10.1038\/3311","journal-title":"Nat Med"},{"issue":"5","key":"13914_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/s0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J et al (2002) \u03b1-Synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322(5):1089\u20131102. https:\/\/doi.org\/10.1016\/s0022-2836(02)00735-0","journal-title":"J Mol Biol"},{"issue":"2","key":"13914_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A 97(2):571\u2013576. https:\/\/doi.org\/10.1073\/pnas.97.2.571","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"13914_CR37","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1039\/d2sc00809b","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W, Tao M, Hong Y et al (2022) Dysfunction of vesicular storage in young-onset Parkinson\u2019s patient-derived dopaminergic neurons and organoids revealed by single cell electrochemical cytometry. Chem Sci 13(21):6217\u20136223. https:\/\/doi.org\/10.1039\/d2sc00809b","journal-title":"Chem Sci"},{"key":"13914_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","volume":"9","author":"A Book","year":"2018","unstructured":"Book A, Guella I, Candido T et al (2018) A Meta-Analysis of alpha-Synuclein Multiplication in Familial Parkinsonism. Front Neurol 9:1021. https:\/\/doi.org\/10.3389\/fneur.2018.01021","journal-title":"Front Neurol"},{"key":"13914_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.849462","author":"P Hua","year":"2022","unstructured":"Hua P, Zhao Y, Zeng Q et al (2022) Genetic analysis of patients with Early-onset Parkinson\u2019s Disease in Eastern China. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.849462","journal-title":"Front Aging Neurosci"},{"issue":"13","key":"13914_CR40","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/mds.23851","volume":"26","author":"KM Kauther","year":"2011","unstructured":"Kauther KM, H\u00f6ft C, Rissling I, Oertel WH, M\u00f6ller JC (2011) The PLA2G6 gene in early-onset Parkinson\u2019s disease. Mov Disord 26(13):2415\u20132417. https:\/\/doi.org\/10.1002\/mds.23851","journal-title":"Mov Disord"},{"issue":"16","key":"13914_CR41","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1128\/mcb.00286-14","volume":"34","author":"B Bj\u00f6rkblom","year":"2014","unstructured":"Bj\u00f6rkblom B, Maple-Gr\u00f8dem J, Puno MR, Odell M, Larsen JP, M\u00f8ller SG (2014) Reactive oxygen species-mediated DJ-1 monomerization modulates intracellular trafficking involving Karyopherin \u03b22. Mol Cell Biol 34(16):3024\u20133040. https:\/\/doi.org\/10.1128\/mcb.00286-14","journal-title":"Mol Cell Biol"},{"key":"13914_CR42","doi-asserted-by":"publisher","unstructured":"Klepac N, Adamec, Margetic, et al. An update on the management of young-onset Parkinson's disease. Degenerative Neurological and Neuromuscular Disease. 2013;https:\/\/doi.org\/10.2147\/dnnd.S34251","DOI":"10.2147\/dnnd.S34251"},{"key":"13914_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/952375","volume":"2013","author":"SV More","year":"2013","unstructured":"More SV, Kumar H, Kim IS, Song S-Y, Choi D-K (2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mediators Inflamm 2013:1\u201312. https:\/\/doi.org\/10.1155\/2013\/952375","journal-title":"Mediators Inflamm"},{"issue":"10","key":"13914_CR44","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nn.3209","volume":"15","author":"JA Goldberg","year":"2012","unstructured":"Goldberg JA, Guzman JN, Estep CM et al (2012) Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson\u2019s disease. Nat Neurosci 15(10):1414\u20131421. https:\/\/doi.org\/10.1038\/nn.3209","journal-title":"Nat Neurosci"},{"key":"13914_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00009","author":"Y-S Chen","year":"2017","unstructured":"Chen Y-S, Chen M-H, Lu C-H et al (2017) Associations among cognitive functions, plasma DNA, and white matter integrity in patients with Early-onset Parkinson\u2019s Disease. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2017.00009","journal-title":"Front Neurosci"},{"issue":"3","key":"13914_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/bj20140006","volume":"458","author":"DE Spratt","year":"2014","unstructured":"Spratt DE, Walden H, Shaw GS (2014) RBR E3 ubiquitin ligases: new structures, new insights, new questions. Biochem J 458(3):421\u2013437. https:\/\/doi.org\/10.1042\/bj20140006","journal-title":"Biochem J"},{"issue":"5","key":"13914_CR47","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen D-F, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183(5):795\u2013803. https:\/\/doi.org\/10.1083\/jcb.200809125","journal-title":"J Cell Biol"},{"issue":"5674","key":"13914_CR48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304(5674):1158\u20131160. https:\/\/doi.org\/10.1126\/science.1096284","journal-title":"Science"},{"issue":"10","key":"13914_CR49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nm1001-1144","volume":"7","author":"KK Chung","year":"2001","unstructured":"Chung KK, Zhang Y, Lim KL et al (2001) Parkin ubiquitinates the \u03b1-synuclein\u2013interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7(10):1144\u20131150. https:\/\/doi.org\/10.1038\/nm1001-1144","journal-title":"Nat Med"},{"issue":"9435","key":"13914_CR50","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S0140-6736(04)16901-8","volume":"364","author":"N Hattori","year":"2004","unstructured":"Hattori N, Mizuno Y (2004) Pathogenetic mechanisms of parkin in Parkinson\u2019s Disease. Lancet 364(9435):722\u2013724. https:\/\/doi.org\/10.1016\/S0140-6736(04)16901-8","journal-title":"Lancet"},{"key":"13914_CR51","doi-asserted-by":"publisher","first-page":"168.e1","DOI":"10.1016\/j.neurobiolaging.2020.03.003","volume":"91","author":"L Krohn","year":"2020","unstructured":"Krohn L, Grenn FP, Makarious MB et al (2020) Comprehensive assessment of PINK1 variants in Parkinson\u2019s disease. Neurobiol Aging 91:168.e1-168.e5. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.03.003","journal-title":"Neurobiol Aging"},{"issue":"3","key":"13914_CR52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/emmm.200900024","volume":"1","author":"E Deas","year":"2009","unstructured":"Deas E, Plun-Favreau H, Wood NW (2009) PINK1 function in health and disease. EMBO Mol Med 1(3):152\u2013165. https:\/\/doi.org\/10.1002\/emmm.200900024","journal-title":"EMBO Mol Med"},{"key":"13914_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx201","author":"K Shiba-Fukushima","year":"2017","unstructured":"Shiba-Fukushima K, Ishikawa K-I, Inoshita T et al (2017) Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson\u2019s disease. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddx201","journal-title":"Hum Mol Genet"},{"key":"13914_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-23","author":"H Nural","year":"2009","unstructured":"Nural H, He P, Beach T, Sue L, Xia W, Shen Y (2009) Dissembled DJ-1 high molecular weight complex in cortex mitochondria from Parkinson\u2019s Disease patients. Mol Neurodegener. https:\/\/doi.org\/10.1186\/1750-1326-4-23","journal-title":"Mol Neurodegener"},{"key":"13914_CR55","doi-asserted-by":"publisher","first-page":"311.e1","DOI":"10.1016\/j.neurobiolaging.2020.05.005","volume":"94","author":"X Gu","year":"2020","unstructured":"Gu X, Li C, Chen Y et al (2020) Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson\u2019s disease. Neurobiol Aging 94:311.e1-311.e4. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.05.005","journal-title":"Neurobiol Aging"},{"issue":"2","key":"13914_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ana.24553","volume":"79","author":"S Olgiati","year":"2016","unstructured":"Olgiati S, Quadri M, Fang M et al (2016) DNAJC Mutations Associated With Early-Onset Parkinson\u2019s Disease. Ann Neurol 79(2):244\u2013256. https:\/\/doi.org\/10.1002\/ana.24553","journal-title":"Ann Neurol"},{"issue":"20","key":"13914_CR57","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2217\/epi-2021-0176","volume":"13","author":"J Meng","year":"2021","unstructured":"Meng J, Wang F, Ji L et al (2021) Comprehensive methylation profile of CSF cfDNA revealed pathogenesis and diagnostic markers for early-onset Parkinson\u2019s disease. Epigenomics 13(20):1637\u20131651. https:\/\/doi.org\/10.2217\/epi-2021-0176","journal-title":"Epigenomics"},{"issue":"6","key":"13914_CR58","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/wnl.51.6.1587","volume":"51","author":"JAG Agundez","year":"1998","unstructured":"Agundez JAG, Jimenez-Jimenez FJ, Luengo A et al (1998) Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson\u2019s disease. Neurology 51(6):1587\u20131592. https:\/\/doi.org\/10.1212\/wnl.51.6.1587","journal-title":"Neurology"},{"key":"13914_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/biom11030433","author":"M Lorente-Pic\u00f3n","year":"2021","unstructured":"Lorente-Pic\u00f3n M, Laguna A (2021) New avenues for Parkinson\u2019s Disease therapeutics: Disease-modifying strategies based on the gut microbiota. Biomolecules. https:\/\/doi.org\/10.3390\/biom11030433","journal-title":"Biomolecules"},{"key":"13914_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101759","author":"M Bi","year":"2022","unstructured":"Bi M, Feng L, He J et al (2022) Emerging insights between gut microbiome dysbiosis and Parkinson\u2019s Disease: Pathogenic and clinical relevance. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2022.101759","journal-title":"Ageing Res Rev"},{"issue":"5","key":"13914_CR61","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s12223-022-00977-2","volume":"67","author":"S Pavan","year":"2022","unstructured":"Pavan S, Prabhu AN, Prasad Gorthi S et al (2022) Exploring the multifactorial aspects of Gut Microbiome in Parkinson\u2019s Disease. Folia Microbiol 67(5):693\u2013706. https:\/\/doi.org\/10.1007\/s12223-022-00977-2","journal-title":"Folia Microbiol"},{"key":"13914_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2021.09.005","volume":"38","author":"S Shandilya","year":"2022","unstructured":"Shandilya S, Kumar S, Jha NK, Kesari KK, Ruokolainen J (2022) Interplay of gut microbiota and oxidative stress: perspective on neurodegeneration and neuroprotection. J Adv Res 38:223\u2013244. https:\/\/doi.org\/10.1016\/j.jare.2021.09.005","journal-title":"J Adv Res"},{"issue":"3","key":"13914_CR63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR et al (2020) Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 23(3):327\u2013336. https:\/\/doi.org\/10.1038\/s41593-020-0589-7","journal-title":"Nat Neurosci"},{"issue":"1","key":"13914_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neulet.2009.11.064","volume":"469","author":"C Godeiro","year":"2010","unstructured":"Godeiro C, de Carvalho Aguiar PM, Fel\u00edcio AC et al (2010) PINK1 polymorphism IVS1\u22127 A\u2192G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinson\u2019s disease. Neurosci Lett 469(1):155\u2013158. https:\/\/doi.org\/10.1016\/j.neulet.2009.11.064","journal-title":"Neurosci Lett"},{"issue":"2","key":"13914_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/enrs.2001.4264","volume":"86","author":"A Priyadarshi","year":"2001","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson\u2019s disease: a metaanalysis. Environ Res 86(2):122\u2013127. https:\/\/doi.org\/10.1006\/enrs.2001.4264","journal-title":"Environ Res"},{"key":"13914_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol 18:95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Pathol"},{"key":"13914_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/genes13030471","author":"F Jia","year":"2022","unstructured":"Jia F, Fellner A, Kumar KR (2022) Monogenic Parkinson\u2019s Disease: Genotype, phenotype, pathophysiology, and genetic testing. Genes. https:\/\/doi.org\/10.3390\/genes13030471","journal-title":"Genes"},{"issue":"3","key":"13914_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mdc3.13428","volume":"9","author":"H Kamo","year":"2022","unstructured":"Kamo H, Oyama G, Nishioka K, Funayama M, Hattori N (2022) Deep brain stimulation for a patient with familial Parkinson\u2019s disease harboring CHCHD2 p.T61I. Mov Disord Clin Pract 9(3):407\u2013409. https:\/\/doi.org\/10.1002\/mdc3.13428","journal-title":"Mov Disord Clin Pract"},{"key":"13914_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081261","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AHV (2022) GBA variants and Parkinson disease: mechanisms and treatments. Cells. https:\/\/doi.org\/10.3390\/cells11081261","journal-title":"Cells"},{"issue":"4","key":"13914_CR70","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ana.25787","volume":"88","author":"S Lesage","year":"2020","unstructured":"Lesage S, Lunati A, Houot M et al (2020) Characterization of recessive Parkinson disease in a large multicenter study. Ann Neurol 88(4):843\u2013850. https:\/\/doi.org\/10.1002\/ana.25787","journal-title":"Ann Neurol"},{"key":"13914_CR71","unstructured":"Br\u00fcggemann N, Klein C. Parkin Type of Early-Onset Parkinson Disease. In: Adam MP, Feldman J, Mirzaa GM, et al, eds. GeneReviews(\u00ae). University of Washington, Seattle Copyright \u00a9 1993\u20132024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.; 1993."},{"key":"13914_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7070071","author":"D Isaacs","year":"2017","unstructured":"Isaacs D, Claassen D, Bowman AB, Hedera P (2017) Phenotypic discordance in siblings with identical compound heterozygous PARK2 mutations. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci7070071","journal-title":"Brain Sci"},{"issue":"Pt 6","key":"13914_CR73","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/awg142","volume":"126","author":"NL Khan","year":"2003","unstructured":"Khan NL, Graham E, Critchley P et al (2003) Parkin disease: a phenotypic study of a large case series. Brain 126(Pt 6):1279\u20131292. https:\/\/doi.org\/10.1093\/brain\/awg142","journal-title":"Brain"},{"issue":"5","key":"13914_CR74","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J et al (2018) Genotype-phenotype relations for the Parkinson\u2019s disease genes Parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord 33(5):730\u2013741. https:\/\/doi.org\/10.1002\/mds.27352","journal-title":"Mov Disord"},{"key":"13914_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2025.100305","author":"L Malfer","year":"2026","unstructured":"Malfer L, Giorgi A, Liu T et al (2026) Heterozygous FBXO7 as potential genetic modifiers in early-onset Parkinson\u2019s disease with levodopa responsive nonmotor features. Brain Disord. https:\/\/doi.org\/10.1016\/j.dscb.2025.100305","journal-title":"Brain Disord"},{"key":"13914_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105855","volume":"116","author":"A Abusrair","year":"2023","unstructured":"Abusrair A, Mititelu A, Pfeffer G, Rosenegger L, Aquino CC (2023) Novel RAB39B variant associated intellectual disability and levodopa-responsive young-onset parkinsonism. Parkinsonism Relat Disord 116:3. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105855","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"13914_CR77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.55697\/tnd.2025.163","volume":"31","author":"T S\u00f6zen Turk","year":"2025","unstructured":"S\u00f6zen Turk T, Acarer A, Durmaz A et al (2025) Investigation of mutations in early-onset Parkinson\u2019s disease through next-generation sequencing analysis. Turk Noroloji Dergisi 31(2):109\u2013117. https:\/\/doi.org\/10.55697\/tnd.2025.163","journal-title":"Turk Noroloji Dergisi"},{"key":"13914_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.parkreldis.2016.04.024","volume":"32","author":"MM Abbas","year":"2016","unstructured":"Abbas MM, Govindappa ST, Sudhaman S et al (2016) Early onset Parkinson\u2019s disease due to DJ1 mutations: An Indian study. Parkinsonism Relat Disord 32:20\u201324. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.024","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR79","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2024.366","author":"VV Holla","year":"2025","unstructured":"Holla VV, Dhar D, Phulpagar P et al (2025) PRKN-gene-related parkinsonism: an experience from a tertiary centre and literature review of Asian cohort. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2024.366","journal-title":"Can J Neurol Sci"},{"issue":"21","key":"13914_CR80","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1212\/01.wnl.0000335167.72412.68","volume":"71","author":"CH Lin","year":"2008","unstructured":"Lin CH, Tan EK, Chen ML et al (2008) Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 71(21):1727\u20131732. https:\/\/doi.org\/10.1212\/01.wnl.0000335167.72412.68","journal-title":"Neurology"},{"issue":"10","key":"13914_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293516","volume":"18","author":"S Thanprasertsuk","year":"2023","unstructured":"Thanprasertsuk S, Phowthongkum P, Hopetrungraung T et al (2023) Levodopa-induced dyskinesia in early-onset Parkinson\u2019s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand. PLoS ONE 18(10):e0293516. https:\/\/doi.org\/10.1371\/journal.pone.0293516","journal-title":"PLoS ONE"},{"issue":"5","key":"13914_CR82","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/ana.25863","volume":"88","author":"CY Kim","year":"2020","unstructured":"Kim CY, Wirth T, Hubsch C et al (2020) Early-onset parkinsonism is a manifestation of thePPP2R5Dp.E200Kmutation. Ann Neurol 88(5):1028\u20131033. https:\/\/doi.org\/10.1002\/ana.25863","journal-title":"Ann Neurol"},{"key":"13914_CR83","doi-asserted-by":"publisher","unstructured":"Kiely AP, Asi YT, Kara E, et al. Clinical and neuropathological features of synucleinopathy associated with G51D SNCA mutation. Movement Disorders. 2013;28((Kiely A.P.; Asi Y.T.; Kara E.; Limousin P.; Ling H.; Lewis P.; Proukakis C.; Quinn N.; Lees A.; Hardy J.; Revesz T.; Houlden H.; Holton J.L.) London, United Kingdom):S277. https:\/\/doi.org\/10.1002\/mds.25605","DOI":"10.1002\/mds.25605"},{"issue":"8","key":"13914_CR84","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.parkreldis.2015.06.005","volume":"21","author":"S Olgiati","year":"2015","unstructured":"Olgiati S, Thomas A, Quadri M et al (2015) Early-onset parkinsonism caused by alpha-synuclein gene triplication: Clinical and genetic findings in a novel family. Parkinsonism Relat Disord 21(8):981\u2013986. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.005","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR85","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1016\/j.jns.2015.08.207","volume":"357","author":"S Elsadig","year":"2015","unstructured":"Elsadig S, Ahmed AA (2015) Outcome of autosomal recessive early onset Parkinson\u2019s disease patients with PINK1 gene-5 year follow-up (2010-2015). J Neurol Sci 357:E51\u2013E51. https:\/\/doi.org\/10.1016\/j.jns.2015.08.207","journal-title":"J Neurol Sci"},{"key":"13914_CR86","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/brain\/awz345","volume":"143","author":"H Morales-Brice\u00f1o","year":"2020","unstructured":"Morales-Brice\u00f1o H, Mohammad SS, Post B et al (2020) Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence. Brain 143:751\u2013770. https:\/\/doi.org\/10.1093\/brain\/awz345","journal-title":"Brain"},{"issue":"1","key":"13914_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jpd-212815","volume":"12","author":"GM Riboldi","year":"2022","unstructured":"Riboldi GM, Frattini E, Monfrini E, Frucht SJ, Di Fonzo A (2022) A practical approach to early-onset parkinsonism. J Parkinsons Dis 12(1):1\u201326. https:\/\/doi.org\/10.3233\/jpd-212815","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"13914_CR88","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/mds.29617","volume":"38","author":"A Di Fonzo","year":"2023","unstructured":"Di Fonzo A, Percetti M, Monfrini E et al (2023) Harmonizing genetic testing for Parkinson\u2019s disease: Results of the PARKNET multicentric study. Mov Disord 38(12):2241\u20132248. https:\/\/doi.org\/10.1002\/mds.29617","journal-title":"Mov Disord"},{"key":"13914_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107852","volume":"135","author":"R Mehanna","year":"2025","unstructured":"Mehanna R, Marras C, Fleisher J et al (2025) Diagnostic work up when suspecting early onset Parkinson disease (EOPD). recommendations from the MDS EOPD study group. Parkinsonism Relat Disord 135:107852. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107852","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-026-01308-9","author":"Z Ye","year":"2026","unstructured":"Ye Z, Zhang S, Liu Z et al (2026) Age at onset of Parkinson\u2019s disease modulates the sphingolipid-dopaminergic interplay in autonomic progression. NPJ Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-026-01308-9","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"13914_CR91","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/mds.870120303","volume":"12","author":"GG Arevalo","year":"1997","unstructured":"Arevalo GG, Jorge R, Garcia S, Scipioni O, Gershanik O (1997) Clinical and pharmacological differences in early- versus late-onset Parkinson\u2019s disease. Mov Disord 12(3):277\u2013284. https:\/\/doi.org\/10.1002\/mds.870120303","journal-title":"Mov Disord"},{"issue":"15","key":"13914_CR92","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1212\/wnl.0000000000002461","volume":"86","author":"G Pagano","year":"2016","unstructured":"Pagano G, Ferrara N, Brooks DJ, Pavese N (2016) Age at onset and Parkinson disease phenotype. Neurology 86(15):1400\u20131407. https:\/\/doi.org\/10.1212\/wnl.0000000000002461","journal-title":"Neurology"},{"issue":"3","key":"13914_CR93","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.23469","volume":"26","author":"MM Wickremaratchi","year":"2011","unstructured":"Wickremaratchi MM, Knipe MDW, Sastry BSD et al (2011) The motor phenotype of Parkinson\u2019s disease in relation to age at onset. Mov Disord 26(3):457\u2013463. https:\/\/doi.org\/10.1002\/mds.23469","journal-title":"Mov Disord"},{"issue":"4","key":"13914_CR94","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s1474-4422(06)70411-2","volume":"5","author":"A Schrag","year":"2006","unstructured":"Schrag A, Schott JM (2006) Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 5(4):355\u2013363. https:\/\/doi.org\/10.1016\/s1474-4422(06)70411-2","journal-title":"Lancet Neurol"},{"issue":"6","key":"13914_CR95","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133(6):1755\u20131762. https:\/\/doi.org\/10.1093\/brain\/awq059","journal-title":"Brain"},{"issue":"4","key":"13914_CR96","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1468-1331.2008.02514.x","volume":"16","author":"MM Wickremaratchi","year":"2009","unstructured":"Wickremaratchi MM, Ben-Shlomo Y, Morris HR (2009) The effect of onset age on the clinical features of Parkinson\u2019s disease. Eur J Neurol 16(4):450\u2013456. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02514.x","journal-title":"Eur J Neurol"},{"issue":"8","key":"13914_CR97","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1136\/jnnp-2014-308786","volume":"86","author":"R Cilia","year":"2015","unstructured":"Cilia R, Cereda E, Klersy C et al (2015) Parkinson\u2019s disease beyond 20 years. J Neurol Neurosurg Psychiatry 86(8):849\u2013855. https:\/\/doi.org\/10.1136\/jnnp-2014-308786","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"13914_CR98","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0404.1994.tb01676.x","volume":"89","author":"A Friedman","year":"2009","unstructured":"Friedman A (2009) Old-onset Parkinson\u2019s disease compared with young-onset disease: clinical differences and similarities. Acta Neurol Scand 89(4):258\u2013261. https:\/\/doi.org\/10.1111\/j.1600-0404.1994.tb01676.x","journal-title":"Acta Neurol Scand"},{"key":"13914_CR99","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.0703","author":"S-M Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad S-M, Romenets SR, Anang JBM, Latreille V, Gagnon J-F, Postuma RB (2015) New clinical subtypes of Parkinson disease and their longitudinal progression. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0703","journal-title":"JAMA Neurol"},{"issue":"s2","key":"13914_CR100","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/jpd-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N, van Laar T (2019) Brain-first versus gut-first Parkinson\u2019s Disease: a hypothesis. J Parkinsons Dis 9(s2):S281\u2013S295. https:\/\/doi.org\/10.3233\/jpd-191721","journal-title":"J Parkinsons Dis"},{"key":"13914_CR101","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.actbio.2021.03.071","volume":"132","author":"AJ Bindas","year":"2021","unstructured":"Bindas AJ, Kulkarni S, Koppes RA, Koppes AN (2021) Parkinson\u2019s disease and the gut: models of an emerging relationship. Acta Biomater 132:325\u2013344. https:\/\/doi.org\/10.1016\/j.actbio.2021.03.071","journal-title":"Acta Biomater"},{"issue":"S11","key":"13914_CR102","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1002\/mds.20458","volume":"20","author":"J Jankovic","year":"2005","unstructured":"Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord 20(S11):S11\u2013S16. https:\/\/doi.org\/10.1002\/mds.20458","journal-title":"Mov Disord"},{"issue":"12","key":"13914_CR103","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/mds.10597","volume":"18","author":"M Bozi","year":"2003","unstructured":"Bozi M, Bhatia KP (2003) Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson\u2019s disease. Mov Disord 18(12):1545\u20131547. https:\/\/doi.org\/10.1002\/mds.10597","journal-title":"Mov Disord"},{"issue":"1","key":"13914_CR104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/mdc3.12007","volume":"1","author":"R Erro","year":"2014","unstructured":"Erro R, Stamelou M, Ganos C et al (2014) The clinical syndrome of paroxysmal exercise-induced dystonia: diagnostic outcomes and an algorithm. Mov Disord Clin Pract 1(1):57\u201361. https:\/\/doi.org\/10.1002\/mdc3.12007","journal-title":"Mov Disord Clin Pract"},{"issue":"2 Part 1","key":"13914_CR105","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1212\/WNL.41.2_Part_1.202","volume":"41","author":"V Kostic","year":"1991","unstructured":"Kostic V, Przedborski S, Flaster E, Sternic N (1991) Early development of levodopa\u2010induced dyskinesias and response fluctuations in young\u2010onset Parkinson\u2019s disease. Neurology 41(2 Part 1):202\u2013202. https:\/\/doi.org\/10.1212\/WNL.41.2_Part_1.202","journal-title":"Neurology"},{"issue":"24","key":"13914_CR106","doi-asserted-by":"publisher","first-page":"e2238","DOI":"10.1212\/wnl.0000000000006643","volume":"91","author":"P Turcano","year":"2018","unstructured":"Turcano P, Mielke MM, Bower JH et al (2018) Levodopa-induced dyskinesia in Parkinson disease. Neurology 91(24):e2238\u2013e2243. https:\/\/doi.org\/10.1212\/wnl.0000000000006643","journal-title":"Neurology"},{"issue":"2","key":"13914_CR107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mds.870020201","volume":"2","author":"N Quinn","year":"1987","unstructured":"Quinn N, Critchley P, Marsden CD (1987) Young onset Parkinson\u2019s disease. Mov Disord 2(2):73\u201391. https:\/\/doi.org\/10.1002\/mds.870020201","journal-title":"Mov Disord"},{"issue":"8","key":"13914_CR108","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/mds.25364","volume":"28","author":"C Warren Olanow","year":"2013","unstructured":"Warren Olanow C, Kieburtz K, Rascol O et al (2013) Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease. Mov Disord 28(8):1064\u20131071. https:\/\/doi.org\/10.1002\/mds.25364","journal-title":"Mov Disord"},{"issue":"4","key":"13914_CR109","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/brain\/awl028","volume":"129","author":"V Sossi","year":"2006","unstructured":"Sossi V, de la Fuente-Fern\u00e1ndez R, Schulzer M, Adams J, Stoessl J (2006) Age-related differences in Levodopa dynamics in Parkinson\u2019s: implications for motor complications. Brain 129(4):1050\u20131058. https:\/\/doi.org\/10.1093\/brain\/awl028","journal-title":"Brain"},{"issue":"5","key":"13914_CR110","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/mdc3.14024","volume":"11","author":"A Mehta","year":"2024","unstructured":"Mehta A, Naheed D, Tan LCS, Neo S (2024) Paradoxical gait response to Levodopa in Parkin-gene-related early-onset Parkinson\u2019s disease: Dopa worsening dystonia. Mov Disord Clin Pract 11(5):580\u2013581. https:\/\/doi.org\/10.1002\/mdc3.14024","journal-title":"Mov Disord Clin Pract"},{"key":"13914_CR111","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.4103\/aian.aian_1110_24","volume":"27","author":"SS Dumpa","year":"2024","unstructured":"Dumpa SS, Pai A (2024) Comparison of motor and non-motor symptoms in young-onset Parkinson S and late-onset Parkinson\u2019s disease. Ann Indian Acad Neurol 27:S262. https:\/\/doi.org\/10.4103\/aian.aian_1110_24. (((Dumpa S.S.; Pai A.) Kasturba Medical College (KMC), Karnataka, Manipal, India))","journal-title":"Ann Indian Acad Neurol"},{"issue":"9","key":"13914_CR112","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s10072-023-06826-5","volume":"44","author":"R Bovenzi","year":"2023","unstructured":"Bovenzi R, Conti M, Degoli GR et al (2023) Shaping the course of early-onset Parkinson\u2019s disease: insights from a longitudinal cohort. Neurol Sci 44(9):3151\u20133159. https:\/\/doi.org\/10.1007\/s10072-023-06826-5","journal-title":"Neurol Sci"},{"key":"13914_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020157","author":"L De Carolis","year":"2023","unstructured":"De Carolis L, Galli S, Bianchini E et al (2023) Age at onset influences progression of motor and non-motor symptoms during the early stage of Parkinson\u2019s disease: A monocentric retrospective study. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13020157","journal-title":"Brain Sci"},{"issue":"12","key":"13914_CR114","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/archneurol.2009.267","volume":"66","author":"RN Alcalay","year":"2009","unstructured":"Alcalay RN, Mejia-Santana H, Tang MX et al (2009) Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol 66(12):1517\u20131522. https:\/\/doi.org\/10.1001\/archneurol.2009.267","journal-title":"Arch Neurol"},{"key":"13914_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120405","volume":"442","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Bozi M, Simitsi AM et al (2022) Clinical differences between early-onset and mid-and-late-onset Parkinson\u2019s disease: data analysis of the Hellenic Biobank of Parkinson\u2019s disease. J Neurol Sci 442:120405. https:\/\/doi.org\/10.1016\/j.jns.2022.120405","journal-title":"J Neurol Sci"},{"issue":"1","key":"13914_CR116","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/cjn.2015.244","volume":"43","author":"LW Ferguson","year":"2016","unstructured":"Ferguson LW, Rajput AH, Rajput A (2016) Early-onset vs. late-onset Parkinson\u2019s disease: A clinical-pathological study. Can J Neurol Sci 43(1):113\u2013119. https:\/\/doi.org\/10.1017\/cjn.2015.244","journal-title":"Can J Neurol Sci"},{"issue":"4-6","key":"13914_CR117","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/02699206.2022.2138784","volume":"37","author":"J B\u00f3na","year":"2023","unstructured":"B\u00f3na J (2023) Speech rate and fluency in young-onset Parkinson\u2019s disease: a longitudinal case study from early to post brain surgery stage. Clin Linguist Phon 37(4\u20136):385\u2013397. https:\/\/doi.org\/10.1080\/02699206.2022.2138784","journal-title":"Clin Linguist Phon"},{"issue":"1","key":"13914_CR118","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00415-012-6600-9","volume":"260","author":"V \u0160pica","year":"2012","unstructured":"\u0160pica V, Pekmezovi\u0107 T, Svetel M, Kosti\u0107 VS (2012) Prevalence of nonmotor symptoms in young-onset versus late-onset Parkinson\u2019s disease. J Neurol 260(1):131\u2013137. https:\/\/doi.org\/10.1007\/s00415-012-6600-9","journal-title":"J Neurol"},{"issue":"11","key":"13914_CR119","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AHV, Stocchi F et al (2007) Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22(11):1623\u20131629. https:\/\/doi.org\/10.1002\/mds.21586","journal-title":"Mov Disord"},{"issue":"10","key":"13914_CR120","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/jnnp-2018-320157","volume":"90","author":"J Pasquini","year":"2019","unstructured":"Pasquini J, Durcan R, Wiblin L et al (2019) Clinical implications of early caudate dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 90(10):1098\u20131104. https:\/\/doi.org\/10.1136\/jnnp-2018-320157","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"13914_CR121","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mds.22899","volume":"25","author":"F Nobili","year":"2010","unstructured":"Nobili F, Campus C, Arnaldi D et al (2010) Cognitive-nigrostriatal relationships in de novo, drug-na\u00efve Parkinson\u2019s disease patients: a [I-123]FP-CIT SPECT study. Mov Disord 25(1):35\u201343. https:\/\/doi.org\/10.1002\/mds.22899","journal-title":"Mov Disord"},{"key":"13914_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117157","author":"R Kim","year":"2020","unstructured":"Kim R, Shin JH, Park S, Kim H-J, Jeon B (2020) Longitudinal evolution of nonmotor symptoms according to age at onset in early Parkinson\u2019s disease. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2020.117157","journal-title":"J Neurol Sci"},{"issue":"7","key":"13914_CR123","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mds.22833","volume":"25","author":"NNW Dissanayaka","year":"2010","unstructured":"Dissanayaka NNW, Sellbach A, Matheson S et al (2010) Anxiety disorders in Parkinson\u2019s disease: prevalence and risk factors. Mov Disord 25(7):838\u2013845. https:\/\/doi.org\/10.1002\/mds.22833","journal-title":"Mov Disord"},{"issue":"9","key":"13914_CR124","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/mds.22897","volume":"25","author":"G K\u00e4gi","year":"2010","unstructured":"K\u00e4gi G, Klein C, Wood NW et al (2010) Nonmotor symptoms in Parkin gene-related parkinsonism. Mov Disord 25(9):1279\u20131284. https:\/\/doi.org\/10.1002\/mds.22897","journal-title":"Mov Disord"},{"issue":"5","key":"13914_CR125","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/mdc3.12671","volume":"5","author":"P Barbosa","year":"2018","unstructured":"Barbosa P, Djamshidian A, Lees AJ, Warner TT (2018) The outcome of Dopamine Dysregulation Syndrome in Parkinson\u2019s disease: a retrospective postmortem study. Mov Disord Clin Pract 5(5):519\u2013522. https:\/\/doi.org\/10.1002\/mdc3.12671","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"13914_CR126","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN et al (2010) Impulse Control Disorders in Parkinson Disease. Archiv Neurol. 67(5):589\u2013595. https:\/\/doi.org\/10.1001\/archneurol.2010.65","journal-title":"Archiv Neurol."},{"key":"13914_CR127","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jns.2016.07.003","volume":"368","author":"L Vela","year":"2016","unstructured":"Vela L, Mart\u00ednez Castrillo JC, Garc\u00eda Ruiz P et al (2016) The high prevalence of impulse control behaviors in patients with early-onset Parkinson\u2019s disease: a cross-sectional multicenter study. J Neurol Sci 368:150\u2013154. https:\/\/doi.org\/10.1016\/j.jns.2016.07.003","journal-title":"J Neurol Sci"},{"issue":"2","key":"13914_CR128","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12031-019-01444-3","volume":"70","author":"J Song","year":"2020","unstructured":"Song J, Shen B, Yang Y-J et al (2020) Non-motor symptoms in Parkinson\u2019s disease patients with Parkin mutations: more depression and less executive dysfunction. J Mol Neurosci 70(2):246\u2013253. https:\/\/doi.org\/10.1007\/s12031-019-01444-3","journal-title":"J Mol Neurosci"},{"issue":"11","key":"13914_CR129","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.parkreldis.2013.06.009","volume":"19","author":"X Guo","year":"2013","unstructured":"Guo X, Song W, Chen K et al (2013) Gender and onset age-related features of nonmotor symptoms of patients with Parkinson\u2019s disease - a study from Southwest China. Parkinsonism Relat Disord 19(11):961\u2013965. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.06.009","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13914_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00677-3","volume":"10","author":"PJ Menon","year":"2024","unstructured":"Menon PJ, Sambin S, Criniere-Boizet B et al (2024) Genotype-phenotype correlation in PRKN-associated Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):72. https:\/\/doi.org\/10.1038\/s41531-024-00677-3","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"13914_CR131","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1007\/s00415-023-11921-w","volume":"270","author":"D Santos-Garcia","year":"2023","unstructured":"Santos-Garcia D, de Deus Fonticoba T, Cores Bartolome C et al (2023) Cognitive impairment and dementia in young onset Parkinson\u2019s disease. J Neurol 270(12):5793\u20135812. https:\/\/doi.org\/10.1007\/s00415-023-11921-w","journal-title":"J Neurol"},{"key":"13914_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107123","volume":"129","author":"K Poplawska-Domaszewicz","year":"2024","unstructured":"Poplawska-Domaszewicz K, Qamar MA, Falup Pecurariu C, Chaudhuri KR (2024) Recognition and characterising nonmotor profile in early onset Parkinson\u2019s disease (EOPD). Parkinsonism Relat Disord 129:107123. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107123","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"13914_CR133","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3233\/jpd-230045","volume":"13","author":"SJ McCarter","year":"2023","unstructured":"McCarter SJ, Camerucci E, Mullan AF et al (2023) Sleep disorders in early-onset parkinsonism: a population-based study. J Parkinsons Dis 13(7):1175\u20131183. https:\/\/doi.org\/10.3233\/jpd-230045","journal-title":"J Parkinsons Dis"},{"key":"13914_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.122784","volume":"455","author":"DT Hoang","year":"2023","unstructured":"Hoang DT, Xing F, Nguyen TD et al (2023) Pain is common in early onset Parkinson\u2019s disease and pain severity is associated with age and worsening of motor and nonmotor symptoms. J Neurol Sci 455:122784. https:\/\/doi.org\/10.1016\/j.jns.2023.122784","journal-title":"J Neurol Sci"},{"key":"13914_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare14020153","author":"A Alenko","year":"2026","unstructured":"Alenko A, Sudhakar M, Chelkeba L, Keygnaert I (2026) Sexual dysfunction in individuals with early-onset Parkinson\u2019s disease in Ethiopia: Gender differences and correlation with anti-Parkinson\u2019s medication, stigma, and distress. Healthcare Basel. https:\/\/doi.org\/10.3390\/healthcare14020153","journal-title":"Healthcare Basel"},{"issue":"6","key":"13914_CR136","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/1877718x251354978","volume":"15","author":"M Derhab","year":"2025","unstructured":"Derhab M, Mullan AF, Turcano P et al (2025) Psychosis in early onset Parkinson\u2019s disease: a retrospective cohort study in southeast Minnesota. J Parkinsons Dis 15(6):1078\u20131085. https:\/\/doi.org\/10.1177\/1877718x251354978","journal-title":"J Parkinsons Dis"},{"key":"13914_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1404904","volume":"15","author":"P Turcano","year":"2024","unstructured":"Turcano P, Jacobson J, Ghoniem K et al (2024) Impulse control disorders and use of dopamine agonists in early onset Parkinson\u2019s disease. Front Neurol 15:1404904. https:\/\/doi.org\/10.3389\/fneur.2024.1404904","journal-title":"Front Neurol"},{"issue":"2","key":"13914_CR138","doi-asserted-by":"publisher","first-page":"84","DOI":"10.14802\/jmd.18048","volume":"12","author":"K Shetty","year":"2019","unstructured":"Shetty K, Krishnan S, Thulaseedharan JV, Mohan M, Kishore A (2019) Asymptomatic hearing impairment frequently occurs in early-onset Parkinson\u2019s disease. J Mov Disord 12(2):84\u201390. https:\/\/doi.org\/10.14802\/jmd.18048","journal-title":"J Mov Disord"},{"issue":"5","key":"13914_CR139","doi-asserted-by":"publisher","first-page":"A285","DOI":"10.1364\/josaa.382042","volume":"37","author":"C Feitosa-Santana","year":"2020","unstructured":"Feitosa-Santana C, Fernandes Costa M, Ballalai Ferraz H et al (2020) Visual losses in early-onset and late-onset Parkinson\u2019s disease. J Opt Soc Am A Opt Image Sci Vis 37(5):A285-a293. https:\/\/doi.org\/10.1364\/josaa.382042","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"issue":"2","key":"13914_CR140","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10072-023-07029-8","volume":"45","author":"R Bovenzi","year":"2024","unstructured":"Bovenzi R, Conti M, Degoli GR et al (2024) Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson\u2019s disease. Neurol Sci 45(2):591\u2013599. https:\/\/doi.org\/10.1007\/s10072-023-07029-8","journal-title":"Neurol Sci"},{"issue":"1","key":"13914_CR141","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00702-024-02811-0","volume":"132","author":"R Bovenzi","year":"2025","unstructured":"Bovenzi R, Conti M, Simonetta C et al (2025) Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson\u2019s disease. J Neural Transm (Vienna) 132(1):61\u201366. https:\/\/doi.org\/10.1007\/s00702-024-02811-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"18","key":"13914_CR142","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","volume":"78","author":"RN Alcalay","year":"2012","unstructured":"Alcalay RN, Caccappolo E, Mejia-Santana H et al (2012) Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology 78(18):1434\u20131440. https:\/\/doi.org\/10.1212\/WNL.0b013e318253d54b","journal-title":"Neurology"},{"key":"13914_CR143","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8610285","volume":"2021","author":"A Planas-Ballve","year":"2021","unstructured":"Planas-Ballve A, Vilas D (2021) Cognitive impairment in genetic Parkinson\u2019s disease. Parkinsons Dis 2021:11. https:\/\/doi.org\/10.1155\/2021\/8610285","journal-title":"Parkinsons Dis"},{"issue":"12","key":"13914_CR144","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/brb3.70182","volume":"14","author":"GY Zhang","year":"2024","unstructured":"Zhang GY, Zhang S, Zhao ZZ, Ma JH, Chan P, Ye Z (2024) Impaired sequential working memory in patients with young onset Parkinson\u2019s disease. Brain Behav 14(12):7. https:\/\/doi.org\/10.1002\/brb3.70182","journal-title":"Brain Behav"},{"key":"13914_CR145","doi-asserted-by":"publisher","first-page":"S848","DOI":"10.1002\/mds.30318","volume":"40","author":"L Sahoo","year":"2025","unstructured":"Sahoo L, Choudhary V, Mishra A (2025) Non-motor symptoms, sleep disturbances, and genetic insights in young onset Parkinson\u2019s disease: A prospective descriptive study. Mov Disord 40:S848\u2013S849. https:\/\/doi.org\/10.1002\/mds.30318. (((Sahoo L.; Choudhary V.; Mishra A.) Bhubaneswar, India))","journal-title":"Mov Disord"},{"issue":"7","key":"13914_CR146","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.clinph.2020.02.030","volume":"131","author":"A Uslu","year":"2020","unstructured":"Uslu A, Ergen M, Demirci H, Lohmann E, Hanagasi H, Demiralp T (2020) Event-related potential changes due to early-onset Parkinson\u2019s disease in parkin (PARK2) gene mutation carriers and non-carriers. Clin Neurophysiol 131(7):1444\u20131452. https:\/\/doi.org\/10.1016\/j.clinph.2020.02.030","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"13914_CR147","doi-asserted-by":"publisher","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","volume":"16","author":"G Pagano","year":"2016","unstructured":"Pagano G, Niccolini F, Politis M (2016) Imaging in Parkinson\u2019s disease. Clin Med Lond 16(4):371\u2013375. https:\/\/doi.org\/10.7861\/clinmedicine.16-4-371","journal-title":"Clin Med Lond"},{"issue":"11","key":"13914_CR148","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/jcbfm.2015.118","volume":"35","author":"T Wu","year":"2015","unstructured":"Wu T, Ma Y, Zheng Z et al (2015) Parkinson\u2019s disease\u2014related spatial covariance pattern identified with resting-state functional MRI. J Cereb Blood Flow Metab 35(11):1764\u20131770. https:\/\/doi.org\/10.1038\/jcbfm.2015.118","journal-title":"J Cereb Blood Flow Metab"},{"key":"13914_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15111245","author":"G Perez Rodriguez Garcia","year":"2025","unstructured":"Perez Rodriguez Garcia G, Middlebrooks E, Mei S et al (2025) Functional and structural connectivity correlates of axial symptom outcomes after pallidal deep brain stimulation in Parkinson\u2019s disease. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci15111245","journal-title":"Brain Sci"},{"key":"13914_CR150","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fnagi.2016.00165","volume":"8","author":"K Sheng","year":"2016","unstructured":"Sheng K, Fang W, Zhu Y et al (2016) Different Alterations of Cerebral Regional Homogeneity in Early-Onset and Late-Onset Parkinson\u2019s Disease. Front Aging Neurosci. 8:165. https:\/\/doi.org\/10.3389\/fnagi.2016.00165","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"13914_CR151","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.parkreldis.2013.11.008","volume":"20","author":"T Tokutake","year":"2014","unstructured":"Tokutake T, Ishikawa A, Yoshimura N et al (2014) Clinical and neuroimaging features of patient with early-onset Parkinson\u2019s disease with dementia carrying SNCA p.G51D mutation. Parkinsonism Relat Disord 20(2):262\u2013264. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.11.008","journal-title":"Parkinsonism Relat Disord"},{"key":"13914_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00915","author":"T Shen","year":"2019","unstructured":"Shen T, Hu J, Jiang Y et al (2019) Early-onset Parkinson\u2019s disease caused by PLA2G6 compound heterozygous mutation, a case report and literature review. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00915","journal-title":"Front Neurol"},{"issue":"2","key":"13914_CR153","first-page":"134","volume":"15","author":"LD Brajkovic","year":"2012","unstructured":"Brajkovic LD, Svetel MV, Kostic VS et al (2012) Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson\u2019s disease. Hell J Nucl Med May-Aug 15(2):134\u2013138","journal-title":"Hell J Nucl Med May-Aug"},{"issue":"1","key":"13914_CR154","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10072-010-0360-z","volume":"32","author":"JF Guo","year":"2011","unstructured":"Guo JF, Wang L, He D et al (2011) Clinical features and 11C -CFT PET analysis of PARK2, PARK6, PARK7-linked autosomal recessive early onset Parkinsonism. Neurol Sci 32(1):35\u201340. https:\/\/doi.org\/10.1007\/s10072-010-0360-z","journal-title":"Neurol Sci"},{"issue":"5","key":"13914_CR155","doi-asserted-by":"publisher","DOI":"10.31083\/jin36989","volume":"24","author":"H Wang","year":"2025","unstructured":"Wang H, Liang Z, Yan Z, Liu Y (2025) Executive dysfunction and prefrontal cortex dysregulation in early-onset Parkinson\u2019s disease: an fNIRS study. J Integr Neurosci 24(5):36989. https:\/\/doi.org\/10.31083\/jin36989","journal-title":"J Integr Neurosci"},{"key":"13914_CR156","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419851400","volume":"12","author":"YJ Yang","year":"2019","unstructured":"Yang YJ, Ge JJ, Liu FT et al (2019) Preserved caudate function in young-onset patients with Parkinson\u2019s disease: a dual-tracer PET imaging study. Ther Adv Neurol Disord 12:1756286419851400. https:\/\/doi.org\/10.1177\/1756286419851400","journal-title":"Ther Adv Neurol Disord"},{"key":"13914_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00141","volume":"14","author":"Y Yue","year":"2020","unstructured":"Yue Y, Jiang Y, Shen T, Pu J, Lai HY, Zhang B (2020) ALFF and ReHo mapping reveals different functional patterns in early- and late-onset Parkinson\u2019s disease. Front Neurosci 14:141. https:\/\/doi.org\/10.3389\/fnins.2020.00141","journal-title":"Front Neurosci"},{"issue":"2","key":"13914_CR158","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/01658107.2019.1652656","volume":"44","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Sharma R, Goyal V, Chaudhary S, Sood SK, Kumaran SS (2020) Saccadic eye movements in young-onset Parkinson\u2019s disease - a BOLD fMRI study. Neuroophthalmology 44(2):89\u201399. https:\/\/doi.org\/10.1080\/01658107.2019.1652656","journal-title":"Neuroophthalmology"},{"issue":"3","key":"13914_CR159","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mds.27946","volume":"35","author":"M Rango","year":"2020","unstructured":"Rango M, Dossi G, Squarcina L, Bonifati C (2020) Brain mitochondrial impairment in early-onset Parkinson\u2019s disease with or without PINK1 mutation. Mov Disord 35(3):504\u2013507. https:\/\/doi.org\/10.1002\/mds.27946","journal-title":"Mov Disord"},{"issue":"S2","key":"13914_CR160","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/ana.21460","volume":"64","author":"AHV Schapira","year":"2009","unstructured":"Schapira AHV, Olanow CW (2009) Drug selection and timing of initiation of treatment in early Parkinson\u2019s disease. Ann Neurol 64(S2):S47\u2013S55. https:\/\/doi.org\/10.1002\/ana.21460","journal-title":"Ann Neurol"},{"issue":"15","key":"13914_CR161","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","volume":"284","author":"Parkinson Study G","year":"2000","unstructured":"Parkinson Study G (2000) Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease. JAMA 284(15):1931\u20131938. https:\/\/doi.org\/10.1001\/jama.284.15.1931","journal-title":"JAMA"},{"issue":"20","key":"13914_CR162","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1056\/nejm200005183422004","volume":"342","author":"O Rascol","year":"2000","unstructured":"Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE (2000) A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa. N Engl J Med 342(20):1484\u20131491. https:\/\/doi.org\/10.1056\/nejm200005183422004","journal-title":"N Engl J Med"},{"issue":"4","key":"13914_CR163","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000197103","volume":"61","author":"T Simuni","year":"2009","unstructured":"Simuni T, Lyons KE, Pahwa R et al (2009) Treatment of early Parkinson\u2019s disease. Eur Neurol 61(4):193\u2013205. https:\/\/doi.org\/10.1159\/000197103","journal-title":"Eur Neurol"},{"issue":"9","key":"13914_CR164","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1212\/wnl.52.9.1908","volume":"52","author":"S Frucht","year":"1999","unstructured":"Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52(9):1908\u20131908. https:\/\/doi.org\/10.1212\/wnl.52.9.1908","journal-title":"Neurology"},{"issue":"9","key":"13914_CR165","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1212\/wnl.57.9.1687","volume":"57","author":"AJ Lees","year":"2001","unstructured":"Lees AJ, Katzenschlager R, Head J, Ben-Shlomo Y (2001) Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology 57(9):1687\u20131694. https:\/\/doi.org\/10.1212\/wnl.57.9.1687","journal-title":"Neurology"},{"issue":"16","key":"13914_CR166","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/mds.21743","volume":"22","author":"RA Hauser","year":"2007","unstructured":"Hauser RA, Rascol O, Korczyn AD et al (2007) Ten-year follow-up of Parkinson\u2019s disease patients randomized to initial therapy with ropinirole or levodopa. Mov Disord 22(16):2409\u20132417. https:\/\/doi.org\/10.1002\/mds.21743","journal-title":"Mov Disord"},{"issue":"5","key":"13914_CR167","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archneurol.2009.32","volume":"66","author":"Parkinson Study Group CALM Cohort Investigators","year":"2009","unstructured":"Parkinson Study Group CALM Cohort Investigators (2009) Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease. Archiv Neurol. 66(5):563\u2013570. https:\/\/doi.org\/10.1001\/archneurol.2009.32","journal-title":"Archiv Neurol."},{"issue":"1","key":"13914_CR168","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/jnnp.2004.036558","volume":"75","author":"A Thomas","year":"2004","unstructured":"Thomas A, Iacono D, Luciano AL, Armellino K, Di Iorio A, Onofrj M (2004) Duration of amantadine benefit on dyskinesia of severe Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 75(1):141\u2013143","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"13914_CR169","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00415-019-09360-7","volume":"266","author":"S Kasamo","year":"2019","unstructured":"Kasamo S, Takeuchi M, Ikuno M et al (2019) Real-world pharmacological treatment patterns of patients with young-onset Parkinson\u2019s disease in Japan: a medical claims database analysis. J Neurol 266(8):1944\u20131952. https:\/\/doi.org\/10.1007\/s00415-019-09360-7","journal-title":"J Neurol"},{"issue":"1","key":"13914_CR170","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldv022","volume":"114","author":"S Mullin","year":"2015","unstructured":"Mullin S, Schapira A (2015) The genetics of Parkinson\u2019s disease. Br Med Bull 114(1):39\u201352. https:\/\/doi.org\/10.1093\/bmb\/ldv022","journal-title":"Br Med Bull"},{"issue":"1","key":"13914_CR171","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2008.929","volume":"301","author":"FM Weaver","year":"2009","unstructured":"Weaver FM (2009) Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial. JAMA 301(1):63\u201373. https:\/\/doi.org\/10.1001\/jama.2008.929","journal-title":"JAMA"},{"issue":"s1","key":"13914_CR172","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/jpd-202104","volume":"10","author":"JM Dijk","year":"2020","unstructured":"Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA, Bloem BR, Brundin P (2020) The choice between advanced therapies for Parkinson\u2019s disease patients: why, what, and when? J Parkinsons Dis 10(s1):S65\u2013S73. https:\/\/doi.org\/10.3233\/jpd-202104","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"13914_CR173","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1007\/s12325-021-01747-1","volume":"38","author":"A Antonini","year":"2021","unstructured":"Antonini A, Odin P, Pahwa R et al (2021) The long-term impact of Levodopa\/Carbidopa intestinal gel on \u2018off\u2019-time in patients with advanced Parkinson\u2019s disease: a systematic review. Adv Ther 38(6):2854\u20132890. https:\/\/doi.org\/10.1007\/s12325-021-01747-1","journal-title":"Adv Ther"},{"issue":"8","key":"13914_CR174","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.22063","volume":"23","author":"PJ Garc\u00eda Ruiz","year":"2008","unstructured":"Garc\u00eda Ruiz PJ, Sesar Ignacio \u00c1, Ares Pensado B et al (2008) Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson\u2019s disease with motor fluctuations: a multicenter study. Mov Disord 23(8):1130\u20131136. https:\/\/doi.org\/10.1002\/mds.22063","journal-title":"Mov Disord"},{"issue":"1","key":"13914_CR175","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00702-015-1441-1","volume":"123","author":"H Reichmann","year":"2015","unstructured":"Reichmann H (2015) Modern treatment in Parkinson\u2019s disease, a personal approach. J Neural Transm 123(1):73\u201380. https:\/\/doi.org\/10.1007\/s00702-015-1441-1","journal-title":"J Neural Transm"},{"issue":"5","key":"13914_CR176","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00415-017-8477-0","volume":"264","author":"\u00c1 Sesar","year":"2017","unstructured":"Sesar \u00c1, Fern\u00e1ndez-Pajar\u00edn G, Ares B, Rivas MT, Castro A (2017) Continuous subcutaneous apomorphine infusion in advanced Parkinson\u2019s disease: 10-year experience with 230 patients. J Neurol 264(5):946\u2013954. https:\/\/doi.org\/10.1007\/s00415-017-8477-0","journal-title":"J Neurol"},{"issue":"9","key":"13914_CR177","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10072-019-03920-5","volume":"40","author":"E Olivola","year":"2019","unstructured":"Olivola E, Fasano A, Varanese S et al (2019) Continuous subcutaneous apomorphine infusion in Parkinson\u2019s disease: causes of discontinuation and subsequent treatment strategies. Neurol Sci 40(9):1917\u20131923. https:\/\/doi.org\/10.1007\/s10072-019-03920-5","journal-title":"Neurol Sci"},{"issue":"6","key":"13914_CR178","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/mds.28599","volume":"36","author":"FAP Nijhuis","year":"2021","unstructured":"Nijhuis FAP, Esselink R, Bie RMA et al (2021) Translating evidence to advanced Parkinson\u2019s disease patients: a systematic review and meta\u2010analysis. Mov Disord 36(6):1293\u20131307. https:\/\/doi.org\/10.1002\/mds.28599","journal-title":"Mov Disord"},{"issue":"3","key":"13914_CR179","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jnnp-2011-300470","volume":"83","author":"A Merola","year":"2012","unstructured":"Merola A, Zibetti M, Artusi CA et al (2012) Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson\u2019s disease: a role for age at disease onset? J Neurol Neurosurg Psychiatry 83(3):251\u2013257. https:\/\/doi.org\/10.1136\/jnnp-2011-300470","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"13914_CR180","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1212\/01.wnl.0000307748.11216.03","volume":"70","author":"E Moro","year":"2008","unstructured":"Moro E, Volkmann J, Konig IR et al (2008) Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology 70(14):1186\u20131191. https:\/\/doi.org\/10.1212\/01.wnl.0000307748.11216.03","journal-title":"Neurology"},{"key":"13914_CR181","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3129","author":"V Krishna","year":"2018","unstructured":"Krishna V, Sammartino F, Rezai A (2018) A review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3129","journal-title":"JAMA Neurol"},{"key":"13914_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153785","author":"OA Abulseoud","year":"2016","unstructured":"Abulseoud OA, Higuchi M-a, Martinez-Ramirez D et al (2016) Interdisciplinary Parkinson\u2019s disease deep brain stimulation screening and the relationship to unintended hospitalizations and quality of life. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0153785","journal-title":"PLoS ONE"},{"key":"13914_CR183","doi-asserted-by":"publisher","first-page":"S1054","DOI":"10.1002\/mds.30318","volume":"40","author":"K Acurio-Ortiz","year":"2025","unstructured":"Acurio-Ortiz K, Hemeryth-Rengifo M, Quispe-Villegas G et al (2025) Deep Brain Stimulation for Early-Onset Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Movem Disord. 40:S1054\u2013S1056. https:\/\/doi.org\/10.1002\/mds.30318","journal-title":"Movem Disord."},{"key":"13914_CR184","doi-asserted-by":"publisher","first-page":"S1039","DOI":"10.1002\/mds.30318","volume":"40","author":"G Hey","year":"2025","unstructured":"Hey G, Kamo H, Rodriguez Garcia G et al (2025) Motor Outcomes Following Subthalamic Nucleus or Globus Pallidus Interna Deep Brain Stimulation in Early-Onset Parkinson\u2019s Disease. Movement Disord 40:S1039\u2013S1040. https:\/\/doi.org\/10.1002\/mds.30318","journal-title":"Movement Disord"},{"key":"13914_CR185","doi-asserted-by":"publisher","first-page":"1177889","DOI":"10.3389\/fnagi.2023.1177889","volume":"15","author":"J Hong","year":"2023","unstructured":"Hong J, Xie H, Chen Y et al (2023) Effects of STN-DBS on cognition and mood in young-onset Parkinson\u2019s disease: a two-year follow-up. Front Aging Neurosci 15:1177889. https:\/\/doi.org\/10.3389\/fnagi.2023.1177889","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"13914_CR186","doi-asserted-by":"publisher","first-page":"941","DOI":"10.32598\/bcn.2025.7579.1","volume":"16","author":"H El Otmani","year":"2025","unstructured":"El Otmani H, Daghi M, Abdallaoui M et al (2025) Subthalamic nucleus deep brain stimulation in early-onset Parkinson\u2019s disease: clinical outcomes in LRRK2 mutation carriers compared to non-carriers. Basic Clinic Neurosci J 16(5):941\u2013948. https:\/\/doi.org\/10.32598\/bcn.2025.7579.1","journal-title":"Basic Clinic Neurosci J"},{"issue":"1","key":"13914_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04593-8","volume":"26","author":"S Chen","year":"2026","unstructured":"Chen S, Yang N, Liu J et al (2026) Effect of deep brain stimulation on early-onset Parkinson\u2019s disease with mutations in a Han Chinese Mainland population. BMC Neurol 26(1):66. https:\/\/doi.org\/10.1186\/s12883-025-04593-8","journal-title":"BMC Neurol"},{"key":"13914_CR188","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2025.2595898","author":"DM Harris","year":"2025","unstructured":"Harris DM, Thwaites C, Callisaya ML et al (2025) Safety and feasibility of implementing gym-based strength training for people with early onset Parkinson\u2019s disease: a phase 1 trial. Disabil Rehabil. https:\/\/doi.org\/10.1080\/09638288.2025.2595898","journal-title":"Disabil Rehabil"},{"issue":"2","key":"13914_CR189","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00702-023-02726-2","volume":"131","author":"C Simonetta","year":"2024","unstructured":"Simonetta C, Bissacco J, Conti M et al (2024) Motor cortex transcranial direct current stimulation improves nonmotor symptoms in early-onset Parkinson\u2019s disease: a pilot study. J Neural Transm (Vienna) 131(2):189\u2013193. https:\/\/doi.org\/10.1007\/s00702-023-02726-2","journal-title":"J Neural Transm (Vienna)"},{"issue":"21","key":"13914_CR190","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","volume":"342","author":"CB Lucking","year":"2000","unstructured":"Lucking CB, Durr A, Bonifati V et al (2000) Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene. N Engl J Med 342(21):1560\u20131567. https:\/\/doi.org\/10.1056\/NEJM200005253422103","journal-title":"N Engl J Med"},{"issue":"12","key":"13914_CR191","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/mds.25132","volume":"27","author":"LL Kilarski","year":"2012","unstructured":"Kilarski LL, Pearson JP, Newsway V et al (2012) Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson\u2019s disease. Mov Disord 27(12):1522\u20131529. https:\/\/doi.org\/10.1002\/mds.25132","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13914-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:22:01Z","timestamp":1783495321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13914-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":191,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13914"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13914-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}}],"article-number":"370"}}